Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...

Creative Biolabs’ integrated workflow addresses challenges in anti-glycopeptide antibody discovery, including weak ...

The Blackstone president and his wife are funding a new Penn institute that uses AI and biomarkers to intercept hereditary cancers at their earliest stages.

Researchers from The University of Texas MD Anderson Cancer Center demonstrated that an artificial intelligence (AI)-based ...

For more than two decades, precision oncology has been promoted as the future of cancer treatment, matching therapies to the unique biology of a patient's tumor.

DelveInsight's DNA Diagnostics Market Insights report provides the current and forecast market analysis, individual leading DNA diagnostics companies' market shares, challenges, DNA diagnostics market ...

Recent advances in single-cell sequencing and spatial multi-omics have transformed our ability to resolve tumor ecosystems at unprecedented resolution.